Prevalence of Tracheotomy and Percutaneous Endoscopic Gastrostomy in Patients with Guillain-Barré Syndrome.
Some patients with Guillain-Barré syndrome require respiratory management by tracheotomy and/or nutritional management by tube feeding; however, few studies have reported the follow-up course in these patients. The objective of this study was to investigate the follow-up course of tracheotomy and gastrostomy in patients with Guillain-Barré syndrome. The study subjects were 50 patients with Guillain-Barré syndrome (25 males, 25 females; mean age, 51.1 ± 18.7 years) who were admitted to the Hiroshima City Rehabilitation Hospital during the period from April 2008 to December 2015. We retrospectively reviewed the medical records to determine the presence or absence of tracheotomy and/or feeding tube, and the timing of withdrawal from these treatments. During the acute phase, 15 patients underwent tracheotomy and 14 underwent tube feeding management. A tracheotomy tube was inserted for 110 days or longer in five patients, and four of these five patients also had a gastrostomy tube inserted. Among the 14 patients in the tube feeding group, seven underwent nasal feeding and seven underwent percutaneous endoscopic gastrostomy. All patients had the nasal tube removed (mean duration of nasal tube placement, 62.1 ± 46.5 days); however, the gastrostomy tube could not be removed in two patients. Our findings indicate that patients in the acute phase of Guillain-Barré syndrome carry a relevant risk of long-term tube feeding and prolonged need of an artificial airway.
Department of Advanced Prosthodontics, Institute of Biomedical & Health Sciences, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima, 734-8553, Japan. mitsu@hiroshima-u.ac.jp.
Mitsuyoshi
0000-0003-2981-4641
M
Yoshida
Department of Neurology, Hiroshima City Rehabilitation Hospital, Hiroshima, Japan.
Junko
J
Ikeda
Speech Therapy Unit, Hiroshima City Rehabilitation Hospital, Hiroshima, Japan.
Yukiko
Y
Urikane
Speech Therapy Unit, Hiroshima City Rehabilitation Hospital, Hiroshima, Japan.
Takashi
T
Kashiwada
Department of Neurology, Hiroshima City Rehabilitation Hospital, Hiroshima, Japan.
Yumiko
Y
Kaseda
Department of Neurology, Hiroshima City Rehabilitation Hospital, Hiroshima, Japan.
Tatsuo
T
Kohriyama
D000208:Acute Disease; D000328:Adult; D000368:Aged; D005260:Female; D005774:Gastrostomy; D020275:Guillain-Barre Syndrome / Q000628:therapy*; D006801:Humans; D007441:Intubation, Gastrointestinal; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors; D014140:Tracheotomy
Deglutition; Deglutition disorders; Guillain–Barré syndrome; Percutaneous endoscopic gastrostomy; Sub-acute rehabilitation hospital; Tracheotomy
J Neurol Neurosurg Psychiatry. 1988 May;51(5):605-12
2841422
J Rehabil Res Dev. 2010;47(1):17-29
20437324
Eur J Phys Rehabil Med. 2014 Aug;50(4):439-46
24651152
Neuroepidemiology. 2009;32(2):150-63
19088488
Ann Neurol. 2010 Jun;67(6):781-7
20517939
Crit Care. 2011;15(1):R65
21338488
Neurology. 1985 Nov;35(11):1662-5
4058758
Eur Neurol. 2001;45(3):133-9
11306855
Dysphagia. 1996 Spring;11(2):93-8
8721066
Am J Med Sci. 2004 Jun;327(6):336-40
15201647
Neurocrit Care. 2006;5(3):230-4
17290095
Neuroepidemiology. 2011;36(2):123-33
21422765
Arch Phys Med Rehabil. 2005 Aug;86(8):1516-20
16084801
BMJ. 2008 Jul 17;337:a671
18640954
Neurology. 2003 Apr 8;60(7):1146-50
12682322
Neurology. 2001 Mar 27;56(6):758-65
11274311
Medicine (Baltimore). 1985 Sep;64(5):333-41
4033410
Lancet Neurol. 2007 Jul;6(7):589-94
17537676
Lancet. 1997 Jan 25;349(9047):225-30
9014908
Lancet. 2005 Nov 5;366(9497):1653-66
16271648